Log in to save to my catalogue

Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza:...

Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7767951

Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study

About this item

Full title

Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study

Publisher

England: John Wiley & Sons, Inc

Journal title

Influenza and other respiratory viruses, 2021-01, Vol.15 (1), p.121-131

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Peramivir offers a single‐dose intravenous (IV) treatment option for influenza (vs 5‐day oral dosing for oseltamivir). We sought to compare outcomes of emergency department (ED) patients at high risk for influenza complications treated with IV peramivir vs oral oseltamivir.
Methods
During the 2015‐16 and 2016‐17 influenza season...

Alternative Titles

Full title

Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7767951

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7767951

Other Identifiers

ISSN

1750-2640

E-ISSN

1750-2659

DOI

10.1111/irv.12794

How to access this item